Rhenman & Partners Asset Management’s ESSA Pharma EPIX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-804,649	Closed	-$4.88M	–	95
2024 Q3	$4.88M	Sell	804,649 -1,405	-0.2%	-$7.72K	0.4%	65
2024 Q2	$4.24M	Sell	806,054 -105,766	-12%	-$672K	0.41%	61
2024 Q1	$7.74M	Buy	911,820 +555,320	+156%	+$4.85M	0.73%	47
2023 Q4	$2.35M	Hold	356,500	–	–	0.24%	72
2023 Q3	$1.1M	Hold	356,500	–	–	0.12%	81
2023 Q2	$963K	Hold	356,500	–	–	0.1%	81
2023 Q1	$1.05M	Sell	356,500 -18,500	-5%	-$54.4K	0.12%	83
2022 Q4	$945K	Hold	375,000	–	–	0.1%	91
2022 Q3	$1.35M	Hold	375,000	–	–	0.14%	88
2022 Q2	$1.18M	Sell	375,000 -35,923	-9%	-$201K	0.13%	86
2022 Q1	$2.54M	Sell	410,923 -9,077	-2%	-$79.8K	0.25%	82
2021 Q4	$5.93M	Sell	420,000 -180,000	-30%	-$2.01M	0.39%	65
2021 Q3	$4.8M	Buy	600,000 +340,000	+131%	+$5.41M	0.34%	76
2021 Q2	$7.43M	Hold	260,000	–	–	0.5%	66
2021 Q1	$7.55M	Buy	260,000 +103,300	+66%	+$2.4M	0.53%	58
2020 Q4	$1.87M	Buy	+156,700	New	+$1.1M	0.15%	78

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rhenman & Partners Asset Management's EPIX Position: Q4 2024 in Review

Rhenman & Partners Asset Management sold out of ESSA Pharma (EPIX) in Q4 2024, closing a stake of 804,649 shares — an estimated $4.88M sold.

Rhenman & Partners Asset Management first reported a position in EPIX in Q4 2020 and held it in 16 quarters. The position peaked at $7.74M in Q1 2024. 46 funds tracked by Wall St. Rank hold EPIX as of Q4 2024.

Rhenman & Partners Asset Management reported no remaining ESSA Pharma position as of Q4 2024 after selling out during the quarter.
Rhenman & Partners Asset Management sold 804,649 ESSA Pharma shares in Q4 2024, an estimated $4.88M.
Rhenman & Partners Asset Management first reported a position in ESSA Pharma in Q4 2020 and held it in 16 quarters.
Rhenman & Partners Asset Management's ESSA Pharma position peaked at $7.74M in Q1 2024.
46 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2024.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.